title: Could Pentoxifylline (PTX) be a promising agent to reduce the systemic inflammation in hemodialysis patients?
authors.forename: Qing
authors.initials: Q
authors.lastname: Ji
authors.forename: Jian
authors.initials: J
authors.lastname: Liu
authors.forename: Dehua
authors.initials: D
authors.lastname: Gong
mesh_terms: D002097:C-Reactive Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use*; D006435:Renal Dialysis; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*
chemical_list: D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein; D010431:Pentoxifylline